These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19999478)

  • 41. Screening for ovarian cancer.
    Emery J; Yaphe J; Priest P; Whiteman D
    Lancet; 1999 Aug; 354(9177):509; author reply 510. PubMed ID: 10465193
    [No Abstract]   [Full Text] [Related]  

  • 42. Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.
    Skates SJ; Horick N; Yu Y; Xu FJ; Berchuck A; Havrilesky LJ; de Bruijn HW; van der Zee AG; Woolas RP; Jacobs IJ; Zhang Z; Bast RC
    J Clin Oncol; 2004 Oct; 22(20):4059-66. PubMed ID: 15381683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare.
    Bast RC
    Trans Am Clin Climatol Assoc; 2004; 115():233-47; discussion 247-8. PubMed ID: 17060970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ovarian cancer screening in women with a family history of breast or ovarian cancer.
    Lacey JV; Greene MH; Buys SS; Reding D; Riley TL; Berg CD; Fagerstrom RM; Hartge P
    Obstet Gynecol; 2006 Nov; 108(5):1176-84. PubMed ID: 17077240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
    Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
    Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ovarian status in healthy postmenopausal women.
    Healy DL; Bell R; Robertson DM; Jobling T; Oehler MK; Edwards A; Shekleton P; Oldham J; Piessens S; Teoh M; Mamers P; Taylor N; Walker F
    Menopause; 2008; 15(6):1109-14. PubMed ID: 18536617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening for ovarian cancer.
    Manassiev N
    Lancet; 1999 Aug; 354(9177):509; author reply 510. PubMed ID: 10465192
    [No Abstract]   [Full Text] [Related]  

  • 48. Enhanced ovarian cancer detection. Two-test combo may identify disease early enough to cure it.
    Duke Med Health News; 2009 Jun; 15(6):8-9. PubMed ID: 19575525
    [No Abstract]   [Full Text] [Related]  

  • 49. Screening for ovarian cancer.
    Chappuis PO; Narod SA; Foulkes WD
    Lancet; 1999 Aug; 354(9177):509-10. PubMed ID: 10465194
    [No Abstract]   [Full Text] [Related]  

  • 50. Current status of screening for ovarian cancer.
    Westhoff C
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S34-7. PubMed ID: 7835807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pre-operative evaluation of ovarian mass: risk of malignancy index.
    Asif N; Sattar A; Dawood MM; Rafi T; Aamir M; Anwar M
    J Coll Physicians Surg Pak; 2004 Mar; 14(3):128-31. PubMed ID: 15228841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of ovarian cancer among women with a CA125 level of 35 U/ml or less.
    Kobayashi H; Yamada Y; Sado T; Sakata M; Yoshida S; Kawaguchi R; Kanayama S; Shigetomi H; Haruta S; Tsuji Y; Ueda S; Kitanaka T; Oi H
    Gynecol Obstet Invest; 2008; 65(2):133-8. PubMed ID: 17957102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Why don't doctors screen for ovarian cancer with annual pelvic ultrasounds like they do mammograms for breast cancer? Is it just a matter of money?
    Robb-Nicholson C
    Harv Womens Health Watch; 1999 Apr; 6(8):8. PubMed ID: 10095276
    [No Abstract]   [Full Text] [Related]  

  • 55. A risk of malignancy index in preoperative diagnosis of ovarian cancer.
    Ma S; Shen K; Lang J
    Chin Med J (Engl); 2003 Mar; 116(3):396-9. PubMed ID: 12781045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CA-125: a biomarker put to the test.
    Schmidt C
    J Natl Cancer Inst; 2011 Sep; 103(17):1290-1. PubMed ID: 21852262
    [No Abstract]   [Full Text] [Related]  

  • 57. [Value of color Doppler ultrasonography, contrast-enhanced ultrasound and serum CA-125 detection in differential diagnosis of ovarian masses].
    Zhou Q; Liu BL; Jiang J; Lei XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2007-9. PubMed ID: 19861251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is there any value in bimanual pelvic examination as a screening test.
    Grover SR; Quinn MA
    Med J Aust; 1995 Apr; 162(8):408-10. PubMed ID: 7746172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of a risk of malignancy index in preoperative diagnosis of ovarian cancer].
    Ma S; Shen K; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Mar; 36(3):162-4. PubMed ID: 11783394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Update on ovarian cancer screening.
    Munkarah A; Chatterjee M; Tainsky MA
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):22-6. PubMed ID: 17218847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.